Skip to main content

Table 2 Distribution of monocyte subsets of PCM-p during the follow-up

From: Phenotypic and functional evaluations of peripheral blood monocytes from chronic-form paracoccidioidomycosis patients before and after treatment

ID patient

Before Treatment

During the treatment

CD45+CD14+

CD14+CD16-

CD14+CD16+

CD14 + CD16++

CD45+CD14+

CD14+CD16-

CD14+CD16+

CD14+CD16++

Length of treatment (months)

P3

348

327

16

5

331

307

6

18

17 (ITC)

P6

933

716

158

58

221

430

16

18

20 (CMX)

P7

1164

959

118

88

776

610

4

23

20 (ITC)

P8

457

346

82

30

214

290

6

10

20 (CMX)

P9

511

350

141

20

273

360

2

15

17 (ITC)

Mean ± SEM

682.6 ± 156.0 A

539.6 ± 127.6

103.0 ± 25.2 A

40.2 ± 14.7

363.0 ± 105.4 B

399.4 ± 58.0

6.8 ± 2.4 B

16.8 ± 2.1

18.8 ± 1.4

  1. Different letters indicate significant differences between the groups (p ≤0.05, t-paired test; A >B).
  2. Values expressed as cell counts/μl.